原发肿瘤部位与皮肤恶性黑色素瘤患者全因及肿瘤特异性死亡风险的关联
该多中心回顾性研究基于SEER数据库2000至2021年数据,纳入162,871例组织学确诊的皮肤恶性黑色素瘤患者,评估原发肿瘤部位与死亡风险的关联。多因素Cox模型显示,与躯干相比,头颈部部位与全因死亡(aHR 1.08,95%CI 1.05-1.12)和肿瘤特异性死亡(aHR 1.05,95%CI 1.02-1.09)风险升高显著相关,而上肢/肩部和下肢/髋部则与死亡风险降低显著相关。
要点
- 头颈部黑色素瘤较躯干的全因死亡风险高8%,肿瘤特异性死亡风险高5%。
- 上肢/肩部和下肢/髋部黑色素瘤较躯干死亡风险显著降低。
- 原发部位应纳入黑色素瘤预后评估和随访策略考量。
核心结论
- 头颈部原发部位与皮肤恶性黑色素瘤患者全因和肿瘤特异性死亡风险升高显著相关,而上肢/肩部和下肢/髋部则与风险降低显著相关。
研究设计与样本
- 多中心回顾性研究,基于SEER项目2000至2021年数据,纳入162,871例组织学确诊的原发性皮肤恶性黑色素瘤患者。
主要发现
- 中位随访6.3年(四分位距2.7-10.9)期间,23.0%患者死亡。
- 多因素Cox模型显示,头颈部较躯干全因死亡aHR为1.08(95%CI 1.05-1.12),肿瘤特异性死亡aHR为1.05(95%CI 1.02-1.09)。
- 上肢/肩部较躯干全因死亡aHR为0.91(95%CI 0.89-0.94),肿瘤特异性死亡aHR为0.79(95%CI 0.75-0.84)。
- 下肢/髋部较躯干全因死亡aHR为0.89(95%CI 0.86-0.92),肿瘤特异性死亡aHR为0.96(95%CI 0.92-1.00)。
- 上述关联在多个亚组和敏感性分析中保持一致。
临床怎么用
- 临床评估黑色素瘤预后时可将原发肿瘤部位作为风险分层参考,头颈部患者需更密切随访。
局限性
- 回顾性设计可能引入选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Existing studies have reported conflicting associations between primary tumor location (PTL) and mortality in patients with cutaneous malignant melanoma (CMM). OBJECTIVE: To evaluate the association of PTL with mortality among patients with CMM. METHODS: This was a multicenter, retrospective study from Surveillance, Epidemiology, and End Results program from 2000 to 2021. Patients with histologically confirmed primary CMM were included. RESULTS: Among 162,871 patients (56.4% male; 74.0% ≥ 50 years), 23.0% died during median 6.3-year follow-up (interquartile range: 2.7-10.9). The multivariate Cox model showed that head and neck [HN] site was significantly associated with increased risk of all-cause (adjusted hazard ratio [aHR]: 1.08, 95% confidence interval [CI]: 1.05-1.12) and cancer-specific mortality (aHR: 1.05, 95% CI: 1.02-1.09), but sites in upper limb/shoulder (ULS) and lower limb/hip (LLH) were significantly associated with decreased risk of all-cause (ULS: aHR: 0.91, 95% CI: 0.89-0.94; LLH: aHR: 0.89, 95% CI: 0.86-0.92) and cancer-specific mortality (ULS: aHR: 0.79, 95% CI: 0.75-0.84; LLH: aHR: 0.96, 95% CI: 0.92-1.00), compared with trunk. The associations were consistent in various subgroups and sensitivity analyses. LIMITATIONS: Retrospective design may introduce selection bias. CONCLUSIONS: HN site has higher risk of all-cause and cancer-specific mortality compared to the trunk site, whereas this effect is reversed at the sites of LLH and ULS.
引用
- Wei S, Su L, Wu L, et al. Association of primary tumor location with all-cause and cancer-specific mortality in cutaneous malignant melanoma patients. J Am Acad Dermatol. 2025. PMID: 41242628. doi:10.1016/j.jaad.2025.11.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。